Neurofilament Light Chain Tech Sheet

Type1 Diabetes Efficacy Studies Tech Sheet

Lupus Efficacy Studies Tech Sheet

Psoriasis Efficacy Studies Tech Sheet

In Vivo Safety and Efficacy Platform for Immunotherapies

C9Orf72 Tech Spec Sheet

The Jackson Laboratory is the exclusive service provider for robust, reliable, reproducible gene therapy, efficacy, and safety studies in the C9orf72 mouse model, the most common form of familial ALS.

Model Generation Services

Our team of subject matter experts will design your new mouse model based on your research goals.

Disaster Preparedness

For over 90 years JAX has been helping researchers reliably and cost-effectively mitigate risk by preserving strains through our reproductive services.

Transgenic Models: FAQ

CRS Studies for CAR T Cell Therapy

Review JAX’s CRS evaluation capabilities and see how a CRS study can help move your CAR T therapeutic into the clinic faster, safer, and more confidently.

Preclinical Drug Development Fact Sheet

A glimpse at the wide range of platforms and services JAX offers to help move you from drug discovery to IND filing.

GvHD Efficacy Study Fact Sheet

An example of study information provided when conducting a GvHD study with the Jackson Laboratory. This example shows Bispecific Antibodies in comparison with Abatacept.

ES Cell Microinjection: FAQ

Diet Composition of Diet-Induced Obesity in Mice

Phenotypes of STZ Mice

STZ-Induced Diabetes: FAQ

Aged NASH Tech Spec Sheet

This document highlights the key differences between aged and young C57BL/6J mice when it comes to NASH.

MSNASH Tech Spec Sheet

Metabolic phenotypes expected from the JAX MSNASH/PcoJ Model

Responding to the Pandemic: What is Next for Post-COVID-19 Research?

Rob Taft, PhD, Senior Services Program Manager at The Jackson Laboratory (JAX) speaks with GEN about how to keep research resilient post-COVID-19.